RE: Rns - director dealing23 Aug 2017 18:00
Not really a confidence boost, although both the Chairman and FD hold big individual stakes out of a float of 3.1bn shares.
Dr Lorenzo Tallarigo's purchase worth £2.6k was made, "under the market share purchase agreement, one-third of Dr Tallarigo's fees as Chairman, after tax, are to be used to purchase shares in Oxford BioMedica PLC on a monthly basis at the prevailing market price. So that's business as usual.
Tim Watts, their CFO, realised options on 8.24m shares, which were granted at 1p. The amount he sold were used to fund the purchase of those options. He now has almost 16m shares worth almost £1.4m